Transformation Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
Non-Hodgkin LymphomaMantle Cell LymphomaFollicular Lymphoma+6 more
BeiGene146 enrolled29 locationsNCT05294731
Recruiting
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation
Beijing University of Chinese Medicine2,000 enrolled2 locationsNCT03261934